9-76707758-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015225.3(PRUNE2):​c.4516T>C​(p.Cys1506Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.775 in 1,613,106 control chromosomes in the GnomAD database, including 486,008 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1506Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.77 ( 45544 hom., cov: 32)
Exomes 𝑓: 0.78 ( 440464 hom. )

Consequence

PRUNE2
NM_015225.3 missense

Scores

1
17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.685

Publications

27 publications found
Variant links:
Genes affected
PRUNE2 (HGNC:25209): (prune homolog 2 with BCH domain) The protein encoded by this gene belongs to the B-cell CLL/lymphoma 2 and adenovirus E1B 19 kDa interacting family, whose members play roles in many cellular processes including apotosis, cell transformation, and synaptic function. Several functions for this protein have been demonstrated including suppression of Ras homolog family member A activity, which results in reduced stress fiber formation and suppression of oncogenic cellular transformation. A high molecular weight isoform of this protein has also been shown to colocalize with Adaptor protein complex 2, beta-Adaptin and endodermal markers, suggesting an involvement in post-endocytic trafficking. In prostate cancer cells, this gene acts as a tumor suppressor and its expression is regulated by prostate cancer antigen 3, a non-protein coding gene on the opposite DNA strand in an intron of this gene. Prostate cancer antigen 3 regulates levels of this gene through formation of a double-stranded RNA that undergoes adenosine deaminase actin on RNA-dependent adenosine-to-inosine RNA editing. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
PCA3 (HGNC:8637): (prostate cancer associated 3) This gene produces a spliced, long non-coding RNA that is highly overexpressed in most types of prostate cancer cells and is used as a specific biomarker for this type of cancer. This gene is embedded in an intronic region of the prune2 gene on the opposite DNA strand. The transcript regulates prune2 levels through formation of a double-stranded RNA that undergoes adenosine deaminase acting on RNA-dependent adenosine-to-inosine RNA editing. In prostate cancer derived cells, overexpression of PCA induced downregulation of prune2, leading to decreased cell proliferation. Conversely, silencing in prostate cancer cells resulted in increased proliferation. Regulation of this gene appears to be sensitive to androgen-receptor activation, a molecular signature of prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.5039994E-7).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.915 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRUNE2NM_015225.3 linkc.4516T>C p.Cys1506Arg missense_variant Exon 8 of 19 ENST00000376718.8 NP_056040.2 Q8WUY3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRUNE2ENST00000376718.8 linkc.4516T>C p.Cys1506Arg missense_variant Exon 8 of 19 5 NM_015225.3 ENSP00000365908.3 Q8WUY3-1

Frequencies

GnomAD3 genomes
AF:
0.771
AC:
117168
AN:
151996
Hom.:
45520
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.710
Gnomad AMI
AF:
0.556
Gnomad AMR
AF:
0.836
Gnomad ASJ
AF:
0.866
Gnomad EAS
AF:
0.936
Gnomad SAS
AF:
0.765
Gnomad FIN
AF:
0.821
Gnomad MID
AF:
0.854
Gnomad NFE
AF:
0.770
Gnomad OTH
AF:
0.812
GnomAD2 exomes
AF:
0.803
AC:
198249
AN:
246946
AF XY:
0.800
show subpopulations
Gnomad AFR exome
AF:
0.710
Gnomad AMR exome
AF:
0.871
Gnomad ASJ exome
AF:
0.859
Gnomad EAS exome
AF:
0.939
Gnomad FIN exome
AF:
0.818
Gnomad NFE exome
AF:
0.774
Gnomad OTH exome
AF:
0.805
GnomAD4 exome
AF:
0.775
AC:
1132517
AN:
1460992
Hom.:
440464
Cov.:
52
AF XY:
0.775
AC XY:
563542
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.708
AC:
23706
AN:
33468
American (AMR)
AF:
0.864
AC:
38565
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.858
AC:
22404
AN:
26122
East Asian (EAS)
AF:
0.958
AC:
38009
AN:
39692
South Asian (SAS)
AF:
0.771
AC:
66440
AN:
86208
European-Finnish (FIN)
AF:
0.814
AC:
43382
AN:
53294
Middle Eastern (MID)
AF:
0.829
AC:
4784
AN:
5768
European-Non Finnish (NFE)
AF:
0.763
AC:
847692
AN:
1111426
Other (OTH)
AF:
0.787
AC:
47535
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
14363
28726
43088
57451
71814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20454
40908
61362
81816
102270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.771
AC:
117256
AN:
152114
Hom.:
45544
Cov.:
32
AF XY:
0.777
AC XY:
57746
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.710
AC:
29452
AN:
41480
American (AMR)
AF:
0.835
AC:
12765
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.866
AC:
3005
AN:
3468
East Asian (EAS)
AF:
0.937
AC:
4853
AN:
5182
South Asian (SAS)
AF:
0.767
AC:
3693
AN:
4818
European-Finnish (FIN)
AF:
0.821
AC:
8685
AN:
10584
Middle Eastern (MID)
AF:
0.857
AC:
252
AN:
294
European-Non Finnish (NFE)
AF:
0.770
AC:
52330
AN:
67978
Other (OTH)
AF:
0.811
AC:
1714
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1334
2669
4003
5338
6672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.777
Hom.:
137185
Bravo
AF:
0.771
TwinsUK
AF:
0.757
AC:
2808
ALSPAC
AF:
0.761
AC:
2934
ESP6500AA
AF:
0.714
AC:
2238
ESP6500EA
AF:
0.764
AC:
5476
ExAC
AF:
0.796
AC:
95737
Asia WGS
AF:
0.845
AC:
2937
AN:
3478
EpiCase
AF:
0.779
EpiControl
AF:
0.787

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
11
DANN
Benign
0.62
DEOGEN2
Benign
0.0098
T;T;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.074
T;T;T
MetaRNN
Benign
8.5e-7
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.;.
PhyloP100
0.69
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.21
N;.;N
REVEL
Benign
0.12
Sift
Benign
0.14
T;.;T
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
0.0
B;.;.
Vest4
0.016
MPC
0.15
ClinPred
0.0077
T
GERP RS
0.64
Varity_R
0.12
gMVP
0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs680775; hg19: chr9-79322674; COSMIC: COSV107481151; COSMIC: COSV107481151; API